Timeline

Juliette Paireau

Research Engineer

26 Aug 2024

publication

Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.

21 Nov 2023

publication

Comparing the Performance of Three Models Incorporating Weather Data to Forecast Dengue Epidemics in Reunion Island, 2018-2019.

08 Nov 2023

publication

Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study.

14 Aug 2023

publication

Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017-2019.

01 Jan 2023

publication

Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.

15 Aug 2022

publication

Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response: Application to the 2017 plague epidemic in Madagascar.

03 May 2022

publication

An ensemble model based on early predictors to forecast COVID-19 health care demand in France.

01 Feb 2022

publication

Early chains of transmission of COVID-19 in France, January to March 2020.

01 Feb 2022

publication

Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France.

01 Jan 2022

publication

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22.

25 Nov 2021

publication

SARS-CoV-2 transmission across age groups in France and implications for control.

01 Aug 2021

publication

Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study.

26 Jul 2021

news

Benefits and risks associated with the COVID-19 vaccine Vaxzevria

01 Jul 2021

publication

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.

01 Jun 2021

publication

Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.

08 Apr 2021

publication

Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study.

12 Mar 2021

publication

Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana.

01 Feb 2021

publication

Age-specific mortality and immunity patterns of SARS-CoV-2.

10 Oct 2020

publication

Lockdown impact on COVID-19 epidemics in regions across metropolitan France.

28 Feb 2019

project

Assessing the threat posed by zoonotic viruses like MERS-CoV, Nipah, Yellow Fever or plague

28 Feb 2019

project

Analysis and modelling to support decision making during epidemics

28 Feb 2019

project

Statistical and mathematical methods to characterize disease transmission from incomplete epidemiological data

18 Mar 2017

project

Improved understanding of patterns of pathogen infection risk

11 May 2015

team

A little guide for advanced search:

Timeline

Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.

Comparing the Performance of Three Models Incorporating Weather Data to Forecast Dengue Epidemics in Reunion Island, 2018-2019.

Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study.

Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017-2019.

Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.

Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response: Application to the 2017 plague epidemic in Madagascar.

An ensemble model based on early predictors to forecast COVID-19 health care demand in France.

Early chains of transmission of COVID-19 in France, January to March 2020.

Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France.

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22.

SARS-CoV-2 transmission across age groups in France and implications for control.

Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study.

Benefits and risks associated with the COVID-19 vaccine Vaxzevria

Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.

Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.

Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study.

Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana.

Age-specific mortality and immunity patterns of SARS-CoV-2.

Lockdown impact on COVID-19 epidemics in regions across metropolitan France.

Assessing the threat posed by zoonotic viruses like MERS-CoV, Nipah, Yellow Fever or plague

Analysis and modelling to support decision making during epidemics

Statistical and mathematical methods to characterize disease transmission from incomplete epidemiological data

Improved understanding of patterns of pathogen infection risk

Mathematical Modelling Of Infectious Diseases